The Technology Impact Award for Researchers in cancer immunotherapies with $200,000 Grant from CRI

The Cancer Research Institute is offering the Technology Impact Award for scientists to address the gap between technology development and clinical application of cancer immunotherapies. The award provides seed funding of up to $200,000 to be used over 12-24 months. 

Award Purpose:-

• These grants aim to encourage collaboration between technology developers and clinical cancer immunologists and to generate the proof-of-principle of a novel platform technology in bioinformatics, ex vivo or in silico modeling systems, immunological or tumor profiling instrumentation, methods, reagents and assays, or other relevant technologies that can enable clinician scientists to generate deeper insights into the mechanisms of action of effective or ineffective cancer immunotherapies.
• The ultimate aim of this program is to advance technologies that can speed up the entire field’s efforts in addressing one of the most defining challenges of our time—developing immunotherapies that are effective for all cancer patients.

Selection Criteria:-

Award winners will be selected based on the novelty, creativity, technical sophistication, and transformative potential of the technology to impact cancer immunotherapy research around the world.

About CRI:-

The Cancer Research Institute is (CRI) a nonprofit organization dedicated to harnessing the human's immune system's power to control and potentially cure all types of cancer. (CRI) funds the most innovative clinical and laboratory research around the world, supports the next generation of the field's leaders, and serves as the trusted source of information on immunotherapy for cancer patients and their caregivers. CRI Works in tandem with its global network of researchers, supporters, patients, and advocates while promoting awareness, sharing up-to-date immunotherapy information, and inspiring lifelong advocacy for the cause.

See more scholarships available on For9a

See more available exchange programs on For9a

• Technology Impact Awards provide up to $100,000 per year for two years. 
• The funds may be used for salary, technical assistance, supplies, capital equipment, or scientific travel. CRI does not provide funds for indirect costs. 
• Payments are made quarterly in U.S. currency to the host institution.

• Applicants must hold a faculty appointment as a tenure-track assistant professor (or higher rank) at the time of award activation. If not, documentation from their institution must accompany the Letter of Intent indicating they will hold the position of assistant professor (or higher rank) by the time of award activation.
• The grant will be awarded to a scientist who describes an extraordinarily novel, yet practical research plan that is creative and technically sophisticated.
• Joint submissions from collaborators will also be considered. (The collaborators will share the award.) Each collaborator must meet the eligibility criteria.
• Selected projects that meet their 12 and 24 month milestones may be eligible for follow-on funding that will enable the established proof-of-concept technology to be developed into a methodology that improves cancer immunotherapy research worldwide.
• The most competitive applicants will address areas where technological innovation stands to benefit the field and cancer patients most, and that will ultimately lead to effective next generation cancer immunotherapies. These technologies may include but are not limited to:
• New bioinformatics methods or technologies that speed collection and analysis of large sets of patient-derived biological data.
• Computer simulations for modeling biological systems and responses to immunotherapy.
• Tools and methods that improve profiling of tumors to inform therapeutic strategies.
• Real-time visualizations of molecular and cellular activity to improve tracking of responses to immunotherapy.
• In vitro tissue culture systems that recapitulate the interactions between primary tumor cells and the immune system.